The Standing Committee on Health, Aged Care and Sport has tabled its report ‘The New Frontier: Delivering better health to all Australians’, following the Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia. 

The three main issues raised in the ASCIA submission to this Parliamentary Inquiry (access to treatments, genomic testing and newborn screening for SCID) that were presented on behalf of ASCIA by Prof Connie Katelaris AM, Prof Jo Douglass and Dr Melanie Wong have been included in the report.

Access to treatments was included in several recommendations and the other issues are specifically mentioned in recommendations 2 (genomic testing) and 21 (newborn screening).  

A link to this report can be found at https://www.aph.gov.au/Parliamentary_Business/Committees/House/Health_Aged_Care_and_Sport/Newdrugs/Report

The ASCIA submission to this Parliamentary Inquiry was lodged in November 2020 and can be found at https://www.allergy.org.au/ascia-reports#s1

This news item was issued on 26 November 2021 by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body for clinical immunology and allergy in Australia and New Zealand.